Commitments and Contingencies - Additional Information (Detail) - USD ($)	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Accrued clinical and contract manufacturing expense	$ 2,800,000	$ 4,800,000
Purchase commitments to be paid in 2023	1,900,000
Incurred collaboration and supply agreement expense	$ 0

Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).

No definition available.

Name:	us-gaap_PurchaseObligationDueInNextTwelveMonths
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant